Erythropoietin administration modulates pulmonary Nrf2 signaling pathway after traumatic brain injury in mice

Journal of Trauma - Injury, Infection and Critical Care

Volumn 71, Issue 3, 2011, Pages 680-686

  Jin, Wei ^a   Wu, Jun ^a   Wang, Handong ^a   Kong, Jie ^a   Ni, Hongbin ^a   Liang, Weibang ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Acute lung injury; Erythropoietin; Nuclear factor erythroid 2 related factor 2; Traumatic brain injury

Indexed keywords

GLUTATHIONE TRANSFERASE; MESSENGER RNA; NAD(P)H:QUINONE OXIDOREDUCTASE 1; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DRY WEIGHT; ENZYME ACTIVITY; HEAD INJURY; LUNG ALVEOLUS CELL; LUNG EDEMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; BRAIN INJURIES; CAPILLARY PERMEABILITY; ERYTHROPOIETIN; LUNG; MALE; MICE; NF-E2-RELATED FACTOR 2; SIGNAL TRANSDUCTION;

EID: 80052739136     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181f6b984     Document Type: Article

References (33)

1. Dettbarn CL, Davidson LJ. Pulmonary complications in the patient with acute head injury: neurogenic pulmonary edema. Heart Lung. 1989;18: 583-589. (Pubitemid 20006307)
2. Holland MC, Mackersie RC, Morabito D, et al. The development of acute lung injury is associated with worse neurologic outcome in patients with severe traumatic brain injury. J Trauma. 2003;55:106-111. (Pubitemid 36919244)
3. Kalsotra A, Zhao J, Anakk S, Dash PK, Strobel HW. Brain trauma leads to enhanced lung inflammation and injury: evidence for role of P4504Fs in resolution. J Cereb Blood Flow Metab. 2007;27:963-974. (Pubitemid 46659024)
4. Shohami E, Gati I, Beit-Yannai E, Trembovler V, Kohen R. Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. J Neurotrauma. 1999;16:365-376. (Pubitemid 29264789)
5. Chen XL, Kunsch C. Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pham Des. 2004;10:879-891. (Pubitemid 38380066)
6. Owuor ED, Kong AN. Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol. 2002;64:765-770. (Pubitemid 35238028)
7. Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol. 2004;37:139-143. (Pubitemid 38608865)
8. Osburn WO, Wakabayashi N, Misra V, et al. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Biochem Biophys. 2006;454:7-15. (Pubitemid 44427746)
9. Jain AK, Bloom DA, Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem. 2005;280:29158-29168. (Pubitemid 41161367)
10. Jin W, Zhu L, Guan Q, et al. Influence of Nrf2 genotype on pulmonary NF-kappaB activity and inflammatory response after traumatic brain injury. Ann Clin Lab Sci. 2008;38:221-227.
11. Jin W, Wang HD, Ji Y, et al. Genetic ablation of Nrf2 enhances susceptibility to acute lung injury after traumatic brain injury in mice. Exp Biol Med (Maywood). 2009;234:181-189.
12. Wu H, Ren B, Zhu J, et al. Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats. Eur J Cardiothorac Surg. 2006;29:902-907. (Pubitemid 43728600)
13. Tascilar O, Cakmak GK, Tekin IO, et al. Protective effects of erythropoietin against acute lung injury in a rat model of acute necrotizing pancreatitis. World J Gastroenterol. 2007;13:6172-6182.
14. Yoshimi M, Maeyama T, Yamada M, et al. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice. Respirology. 2008;13:639-645. (Pubitemid 351977594)
15. Hall ED. High-dose glucocorticoid treatment improves neurological recovery in head-injured mice. J Neurosurg. 1985;62:882-887. (Pubitemid 15009416)
16. Jin W, Wang HD, Yan W, et al. Role of Nrf2 in protection against traumatic brain injury in mice. J Neurotrauma. 2009;26:131-139.
17. Mikrogianakis A, Shaye RE, Griffin P, et al. Hypoxia alters the expression of inhibitor of apoptosis proteins after brain trauma in the mouse. J Neurotrauma. 2007;24:338-353. (Pubitemid 46492155)
18. Yatsiv I, Grigoriadis N, Simeonidou C, et al. Erythropoietin is neuro-protective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J. 2005;19:1701-1703. (Pubitemid 41429535)
19. Zhu L, Jin W, Pan H, et al. Erythropoietin inhibits the increase of intestinal labile zinc and the expression of inflammatory mediators after traumatic brain injury in rats. J Trauma. 2009;66:730-736.
20. Wagner EM, Karagulova G, Jenkins J, Bishai J, McClintock J. Changes in lung permeability after pulmonary artery obstruction. J Appl Physiol. 2006;100:1224-1229. (Pubitemid 43671480)
21. Lv R, Zhou W, Chu C, Xu J. Mechanism of the effect of hydroxyethyl starch on reducing pulmonary capillary permeability in a rat model of sepsis. Ann Clin Lab Sci. 2005;35:174-183. (Pubitemid 40677111)
22. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349. (Pubitemid 30408719)
23. Ware LB, Kaner RJ, Crystal RG, et al. VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema. Eur Respir J. 2005;26:101-105. (Pubitemid 40945937)
24. Kawkitinarong K, Linz-McGillem L, Birukov KG, Garcia JG. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am J Respir Cell Mol Biol. 2004;31:517-527. (Pubitemid 39463400)
25. Byts N, Sirén AL. Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med. 2009;1:4.
26. Mammis A, Mclntosh TK, Maniker AH. Erythropoietin as a neuroprotective agent in traumatic brain injury review. Surg Neurol. 2009;71: 527-531.
27. Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett. 2007;425:177-182. (Pubitemid 47418362)
28. Xiong Y, Mahmood A, Qu C, et al. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma. 2010;27: 205-215.
29. Katavetin P, Inagi R, Miyata T, et al. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun. 2007;359:928-934. (Pubitemid 46946906)
30. Genc K, Egrilmez MY, Genc S. Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells. Cell Biochem Funct. 2010;28:197-201.
31. Kumral A, Gonenc S, Acikgoz O, et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate. 2005;87:15-18. (Pubitemid 40091371)
32. Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A. 2000;97:10526-10531.
33. Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med. 2003;198:971-975. (Pubitemid 37152934)